These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2120080)

  • 21. Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction.
    Bhatnagar A; Liu S; Das B; Srivastava SK
    Mol Pharmacol; 1989 Dec; 36(6):825-30. PubMed ID: 2513474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
    Bank N; Coco M; Aynedjian HS
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
    Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
    J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
    Gonzalez AM; Sochor M; McLean P
    Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on L-threose as substrate for aldose reductase: a possible role in preventing protein glycation.
    Devamanoharan PS; Varma SD
    Mol Cell Biochem; 1996 Jun; 159(2):123-7. PubMed ID: 8858562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional and structural studies of alpha-crystallin from galactosemic rat lenses.
    Huang FY; Ho Y; Shaw TS; Chuang SA
    Biochem Biophys Res Commun; 2000 Jun; 273(1):197-202. PubMed ID: 10873586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of aldose reductase inhibitors by determination of IC50 with bovine and rat lens extracts.
    Müller P; Hockwin O; Ohrloff C
    Ophthalmic Res; 1985; 17(2):115-9. PubMed ID: 3920598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A; Ku L; Cohen MP
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein alterations in age-related cataract associated with a persistent hyaloid vascular system in senescence-accelerated mouse (SAM).
    Ashida Y; Takeda T; Hosokawa M
    Exp Eye Res; 1994 Oct; 59(4):467-73. PubMed ID: 7859822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lambda-crystallin related to dehydroascorbate reductase in the rabbit lens.
    Suzuki T; Bando M; Oka M; Tsukamoto H; Akatsuka I; Kawai K; Obazawa H; Kobayashi S; Takehana M
    Jpn J Ophthalmol; 2003; 47(5):437-43. PubMed ID: 12967857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Edelist T; Varagiannis E
    Pharmacology; 1986; 32(1):52-60. PubMed ID: 3080763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldose reductase activity and basement membrane thickening.
    Frank RN
    Metabolism; 1986 Apr; 35(4 Suppl 1):35-40. PubMed ID: 3083207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.
    Ranjan M; Nayak S; Rao BS
    Mol Vis; 2006 Sep; 12():1077-85. PubMed ID: 17093392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
    Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
    J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of lens crystallins photosensitized with tryptophan metabolites.
    Ichijima H; Iwata S
    Ophthalmic Res; 1987; 19(3):157-63. PubMed ID: 3658326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.